Wyeth Rejects Claim That It Promoted Off-Label Prescribing
By Dani Kass · November 13, 2015, 4:19 PM EST
Pfizer's Wyeth Pharmaceuticals Inc. on Thursday told a Massachusetts federal court that a whistleblower can't prove the drugmaker encouraged physicians to prescribe its acid reflux drug off label, as part of...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login